Hospital Universitario Reina Sofia — Clinical Trial Site

509 Registered trials

193 Currently recruiting

Organisation

Hospital Universitario Reina Sofia

Location

Cordoba, Spain

Identifier

ORG-100041195

Address

Avenida Menendez Pidal S/n, 14004, Spain

Departments

#034019 Oncología Médica
#1906: Cardiología
#2036:Hematology
#2163 pediatrics
#2202:Servicio Medicina Interna
#2308:servicio de neurología
#2355: Servicio de dermatología
#2407: Neurología
#2907; Medicina interna
#3407: Medicina Interna
#3407:Reumatología
#3807:UCI/medicina intensiva
#40046: Reumatologia
#40046: Servicio de Neurología
#4006:Hematología
#40105: Reumatologia
#40105: Servicio de Neurologia
#4208:Servicio Medicina Interna
#4506: Cardiología
#7004: Servicio Neurología
#7007: Cirugía General y Aparato Digestivo
#8002: Oncología Médica
#9112: Hematologia
03401: Oncología Médica
1309: Oncología Médica
1403:Dermatología
1407: Reumatología
2032:Nefrología
2457: Reumatología
2501:Oncología
2802: Medicina Interna
3002; Enfermedades Infecciosas
3102: medicina interna
3310: Oncologia
34014: Oncología Médica
3614: Oncología Médica
4208: Medicina Interna
4256:Reumatologia
6503: Dermatología
6903: Oncología
7007:Oncología Médica
7013: Oncología Médica
7020: Oncología Medica
724011: Oncología Médica
7503 Rheumatology
Allergology
Allergology-Pediatric
Anesthesiology - Pain Unit
Aparato Digestivo
Cardiología
Cardiologia pediatrica
Cardiologia pediatrica - Patient Visits
Cardiology
Cardiology Dept
Cardiovascular surgery
Cirugía
Cirugía General
Cirugía Maxilofacial
D10-542 : Nephrology
Departament of Dermatology
Departamento de dermatologia
Departamento de Neurología
Department of Infectious Diseases
Department of Ophthalmology
Department of Urology
Dermathology unit
Dermatologia
Dermatology
Dermatology Department
Digestive
Digestive Department
Digestive system
Digestivo
Endocrinology
Enfermedades Infecciosas
ES10005: Aparato Digestivo
ES10005: Reumatología
ESP0602: Oncología
Gastroenterology
Gastroenterology and Hepatology
General and Digestive Surgery
General and Digestive Surgery Unit, and Abdominal Organ Transplantation
Gestión Clínica de Endocrinología y Nutrición
Hematología
Hematology
Hepathology
Hepatología
Hepatology
Immunology
Infecciosas
Infectious Disease
Infectious Diseases
Infectious diseases service
Intensive Care medicine
Intensive Care Unit
Intensive Medicine
Internal Medicin
Internal Medicine
Internal Medicine department-Infectious diseases
Lipidology
Medical oncology
Medical Oncology Department
Medicina Interna
Medicina Nuclear
N/A
na
Nefrology
Nephrology
Neprology
Neurología
Neurology
NEUROSURGERY SERVICE
Obstetrics-Gynecology
Oncologia
Oncología Médica
Oncology
Oncology Department
Oncology service
Pediatría
Pediatria. Unidad de Gastroenterologia y Nutricion
Pediatric
Pediatric Endocrinology
Pediatric Gastroenterology
Pediatric Surgery
Pediatry
Preventive Medicine
Psychiatry
Psychiatry Department
Pulmonology
Radiodiagnosis and Breast Cancer
Radiotherapy Oncology
Raumatology
Reumatologia
Reumatology
Rheumatologist
Rheumatology
Rheumatology Department
Rheumatology Service
Serivicio de enfermedades infecciosas
Servicio de Cardiología
Servicio de Cardiología de Medicina Interna
Servicio de Dermatología
Servicio de Digestivo
Servicio de enfermedades Infecciosas
Servicio de Hematologia
Servicio de Hepatología-Transplante hepático
Servicio de Medicina Interna
Servicio de Nefrologia
Servicio de Neurología
Servicio de Obstetricia y Ginecología
Servicio de Oftalmología
Servicio de Oncología
Servicio de Oncologia Médica
Servicio de Oncología y Hematología Pediátricas
Servicio de Pediatría
Servicio de Reumatología
Servicio de Urología
Servicio Enfermedades Infecciosas
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
UGC Enfermedades Infecciosas
UGC Enfermedades Infecciosas. Planta 6.
Unidad de Cirugía Cardiovascular
Unidad de Lípidos y Arteriosclerosis
Urología
Urological department
Urology

Clinical trials at this site (509)

Search interface

Trial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab versus Chemotherapy Plus Trastuzumab Plus or Minus … Recruiting

2024-513122-27-00 Unresectable, Locally Advanced or Metastatic HER2 posit 5 2025-06-10
EORTC-2238-GUCG: Improving impact of anti-androgen treatments on patient's daily life and their cancer Recruiting

2023-506817-23-01 Metastatic hormone naïve prostate cancer (mHNPC) 5 2025-05-23
A Phase 3 Study Comparing BMS-986365 versus Investigator’s Choice of Therapy in Participants with Metastatic Castration-resistant Prostate C… Recruiting

2024-517422-25-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-05-22
A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting

2024-517513-32-00 Sjögren’s Syndrome 5 2025-05-16
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-experienced Participants with Active Psoriatic Arthritis Recruiting

2024-517284-23-00 Active Psoriatic Arthritis 5 2025-04-23
A Study to Test the Effectiveness and Safety of RO7790121 for induction and maintenance therapy in Patients with Moderately to Severely Acti… Recruiting

2024-513053-69-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
A multicenter, single-arm, open-label study to evaluate efficacy and safety of switching from anti-C5 antibody treatment to iptacopan treatm… Recruiting

2023-504550-35-00 Atypical Hemolytic Uremic Syndrome (aHUS) 5 2025-04-03
A study in newly diagnosed glioblastoma patients that aims at testing the efficacy of Optune (Tumor Treating Fields), together with temozolo… Recruiting

2024-513550-30-00 Newly diagnosed Glioblastoma 5 2025-03-28
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast C… Recruiting

2024-515445-42-00 Node-positive, Estrogen Receptor-positive, HER2-negativ 5 2025-03-24
A safety and efficacy study of RTX001 autologous macrophage therapy in participants with decompensated liver cirrhosis Recruiting

2024-516288-10-00 Liver Cirrhosis 9 2025-03-21
Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Ca… Recruiting

2022-502352-31-00 Colorectal Cancer (CRC) 5 2025-02-10
A study describing the efficacy and safety of belimumab administered subcutaneously in adult participants with early systemic lupus erythema… Recruiting

2023-509146-35-00 Systemic Lupus Erythematosus 6 2025-01-30
Fast-Track Therapeutic Model in Complicated Acute Appendicitis Recruiting

2025-520777-39-00 Complicated acute appendicitis 6 2025-01-29
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease ( ENHANCE-CD ) Recruiting

2023-508234-34-00 Crohn's disease 4 2025-01-27
COLCHICINE IN SECONDARY PREVENTION OF VASCULAR EVENTS AND RENAL PROGRESSION IN PATIENTS WITH MODERATE CHRONIC RENAL DISEASE Recruiting

2023-505868-11-00 CHRONIC RENAL DISEASE 5 2025-01-17
A study to evaluate the efficacy and safety of frexalimab, brivekimig or rilzabrutinib in participants aged 16 to 75 years with primary foca… Recruiting

2024-511775-15-00 Immune system diseases 4 2025-01-17
PROMETEO-HG Recruiting

2024-516561-37-01 Metabolic Associated Fatty Liver Disease with prediabet 5 2024-12-19
Treatment with a single drug that prevents blood clot formation followed by an anticoagulant drug in patients with irregular heartbeat who h… Recruiting

2023-509717-36-00 AF patients who have undergone successful PCI 5 2024-12-16
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared … Recruiting

2023-504022-19-01 Polymyositis or dermatomyositis according to 2017 EULAR 5 2024-12-13
A clinical trial to learn about the effects of YTB in people with difficult to treat active systemic lupus erythematosus (SLE), or active k… Recruiting

2023-510150-17-00 Active, refractory systemic lupus erythematosus (SLE), 4 2024-12-11
A clinical trial to learn about the effects of YTB323 in people with difficult to treat severe diffuse cutaneous systemic sclerosis (dcSSc) Recruiting

2023-510380-34-00 Diffuse cutaneous systemic sclerosis (dcSSc) 4 2024-12-10
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subject… Recruiting

2024-513860-25-00 Ovarian Neoplasms 9 2024-12-10
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer … Recruiting

2024-512279-10-00 Triple Negative Breast Cancer 5 2024-11-25
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2024-11-07